This is a routine administrative filing with no actionable trading signal. Monitor upcoming H1 2026 earnings release for financial performance updates.
GMAB drugs
GMAB drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Aug 12 $31.42entry
- T+1 · 3mo ago −0.25%α −0.95% · $31.34
- T+5 · 3mo ago +8.56%α +9.01% · $34.11
- T+20 · 2mo ago +2.58%α +4.48% · $32.23
- T+60 · 12d ago +75.43%α +80.31% · $55.12
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Genmab A/S filed its updated Articles of Association on August 11, 2026, via a Form 6-K on August 12, 2026. The filing is a routine corporate governance update, renewing existing authorizations for the Board of Directors to issue shares and warrants for employee incentive programs through March 2029/2030. The document details the terms of employee warrant schemes, including vesting schedules and exercise prices. No material financial data, changes in business operations, or new strategic initiatives were disclosed. The filing is administrative in nature and does not contain information that would materially impact the company's stock price.
Key Facts
- Genmab filed an updated set of Articles of Association on August 11, 2026.
- The Board of Directors' authorization to increase share capital without pre-emption rights (up to DKK 6.6M) is renewed through March 12, 2029.
- The Board of Directors' authorization to issue convertible debt instruments (up to DKK 3M nominal) is renewed through March 12, 2029.
- Multiple employee warrant schemes are detailed, with grants issued from 2017 through June 2026, all with exercise prices at or above market price at time of grant.
- The filing is a routine corporate governance update with no financial results or operational changes.
Financial Impact
No financial impact. The filing is a routine update of corporate governance documents with no new financial data.
Risk Factors
- No material risks identified from this filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 10 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (GMAB), Batch item 1 | 0001434265-26-000113 |
| Document: gmab_20260812x6k.htm | 0001434265-26-000113 |
| Document: 0001434265-26-000113-index-headers.html | 0001434265-26-000113 |
| Document: 0001434265-26-000113-index.html | 0001434265-26-000113 |
| Document: 0001434265-26-000113.txt | 0001434265-26-000113 |
| 6-K Filing (GMAB), Batch item 6 | 0001434265-26-000113 |
| Document: gmab_20260812x6k.htm | 0001434265-26-000113 |
| Document: 0001434265-26-000113-index-headers.html | 0001434265-26-000113 |
| Document: 0001434265-26-000113-index.html | 0001434265-26-000113 |
| Document: 0001434265-26-000113.txt | 0001434265-26-000113 |
Track record
31 reports on GMAB
3 of 5 bullish or bearish reports moved the stock their way by T+20. Best: +91.28% at T+60 after the Aug 6, 2026 report. 5 of 7 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $52.12 Now $51.57 −1.06% settles Dec 15
- Nov 12, 20264d ago 6-K Neutral 2/10 Entry $51.74 Now $51.57 −0.33% settles Dec 11
- Nov 12, 20264d ago 6-K Neutral 2/10 Entry $51.74 Now $51.57 −0.33% settles Dec 11
- Nov 12, 20264d ago 6-K Neutral 2/10 Entry $51.74 Now $51.57 −0.33% settles Dec 11
- Nov 12, 20264d ago 6-K Neutral 2/10 Entry $51.74 Now $51.57 −0.33% settles Dec 11
- Nov 10, 20266d ago 6-K Neutral 2/10 Entry $53.87 Now $51.57 −4.27% settles Dec 10
- Nov 10, 20266d ago 144 Neutral 2/10 Entry $54.07 Now $51.57 −4.62% settles Dec 9
- Nov 5, 202611d ago 6-K Neutral 5/10 Entry $52.74 Now $51.57 −2.22% settles Dec 4
- Nov 4, 202612d ago Institutional Cluster Neutral 2/10 Entry $52.74 Now $51.57 −2.22% settles Dec 4
- Oct 28, 202619d ago 6-K Bullish 6/10 Entry $57.29 Now $51.57 −9.98% settles Nov 25
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers